Samantha Fraser-Bell, EURETINA 2019 – Results of the AUSSIDEX study
Samantha Fraser-Bell (University of Sydney) caught up with us to share the latest results of the AUSSIDEX study, and discuss the real-world impact on patients with DME.
1. What are the main challenges you face when treating patients with diabetic macular oedema? (0:04)
2. Tell us about your current research in this area (0:31)
3. How can the results impact real world practice? (1:58)
4. What do you expect to be the key talking points at this year’s EURETINA meeting? (2:24)
Support: No funding was received in the production of this video.
Share this Video
Related Videos In Retina/Vitreous
Carl Regillo, Hawaiian Eye and Retina 2023: New and emerging treatments for neovascular age-related macular degeneration
It was a pleasure to catch up with Dr Carl Regillo (Wills Eye Hospital, Philadelphia, PA, USA) about new and emerging neovascular age-related macular degeneration treatments, including the new anti-vascular endothelial growth factor which appear to lead to better outcomes with durability, which is one of the biggest unmet needs in treatment of age-related macular […]
Carl Regillo, Hawaiian Eye and Retina 2023: Vascular endothelial growth factor inhibitors – real-world versus clinical trial outcomes
It was a pleasure to catch up with Dr Carl Regillo (Wills Eye Hospital, Philadelphia, PA, USA) about the problems with the clinical utility of vascular endothelial growth factor inhibitors and the issues around durability and ensuring good outcomes in real-world settings, as opposed to just in clinical trials. Questions: How do age-related macular degeneration […]
Roxane Hillier, EURETINA 2022: Mechanisms of action in rhegmatogenous retinal detachment repair (Part 1)
It was a pleasure to talk to Roxane Hillier (Newcastle Eye Centre, Newcastle, UK) on her EURETINA course on rhegmatogenous retinal detachment repair. In this interview, she discussed the treatment options for rhegmatogenous retinal detachment. The instructional course entitled “Mechanisms of Action in Rhegmatogenous Retinal Detachment Repair” was conducted at EURETINA 2022, 1–4 September 2022 […]
Journal articles and more to your inbox
Get the latest clinical insights from touchOPHTHALMOLOGYSign me up!